22 results
8-K
SAVA
Cassava Sciences Inc
13 Sep 23
Amendments to Articles of Incorporation or Bylaws
4:17pm
on behalf of the Company and of certain actions relating to fiduciary and other internal corporate matters; (6) adopt gender-neutral terms when referring
8-K
EX-99.1
8c8ldy9oq42 vf6yjgw4
8 Feb 21
Regulation FD Disclosure
4:09pm
8-K
EX-1.1
icapfg40f9 dfv1lw
13 Nov 20
Cassava Sciences Announces Proposed Public Offering of Common Stock
4:36pm
8-K
EX-99.1
yzb tsh9pg
14 Sep 20
Regulation FD Disclosure
4:01pm
8-K
EX-99.2
muw58tih6gc1yg3hx7c0
14 Sep 20
Regulation FD Disclosure
4:01pm
8-K
EX-99.1
47fvftbn1rifgzg
21 Apr 05
Pain Therapeutics Announces First Quarter 2005 Financial Results
12:00am
424B5
h2yvgzwrrh0enmqd
8 Oct 04
Prospectus supplement for primary offering
12:00am
424B5
83z7 oavc88jt2wo3h
22 Sep 04
Prospectus supplement for primary offering
12:00am
424B1
rhxa i3uxg1fge
22 Sep 03
Prospectus with pricing info
12:00am